Blood test strategy could improve IBD treatment and cut costs
NCT ID NCT02508012
Summary
This study tested whether regularly checking the level of anti-TNF drugs in a patient's blood helps manage Crohn's disease and ulcerative colitis more effectively. 260 patients were split into two groups: one where doctors used these blood test results to adjust treatment, and one where they did not. The main goal was to see if this monitoring approach leads to better health outcomes and is cost-effective over two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University hospital
Montpellier, 34295, France
Conditions
Explore the condition pages connected to this study.